Home
ACTL Immunotherapy
Functional Mechanism
Advantages
Safety
Indications
Protocols
Steps
Patents
Translational Medicine
Treatment & Prevent
Conditions
Case Studies
Cooperative Hospital
Early Detection
Prevention
Nursing & Care
News
Partnership
About Us
Company Introduction
Our Culture
Milestones
Qualification & Honor
Team of Experts
Activities
Jobs
Contact Us
简体
繁体
英文
Coperate News
Coperate News
Industrial News
Policies & Regulations
08-21 2012
ISKCON participated in the 6th CSCO-South Conference, and the ACTL Technical Symposium was a complete success!
On August 17, 2013, Zhujiang Hotel, Guangzhou. The 6th "CSCO-S...
Details
08-19 2012
Congratulations on the successful approval of ISKCON’s application for "2012 Shenzhen Innovation Committee Innovation Funding Project"
The 2012 Shenzhen Innovation Committee Innovation Funding Project declared by our company was...
Details
08-10 2012
ISKCON and Shenzhen Second People's Hospital signed a scientific research cooperation agreement
On August 20, 2013, Dean Cai of Shenzhen Second People's Hospital visited the company and in...
Details
08-10 2012
ISKCON and Nanfang Hospital signed a scientific research cooperation agreement
On August 9, 2012, the company signed an ACTL technology research cooperation agreement with N...
Details
08-10 2012
Congratulations to ISKCON for its successful declaration of "2012 Nanshan District Independent Innovation Industry Development Special Fund Technology Project"!
Congratulations on the successful application of the ACTL technology "targeted anti-prostate ca...
Details
First
<<
6
7
8
9
10
>>
